Press release
Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market : A Key Catalyst Accelerating Global PEGylated Proteins Market Growth in 2025
PEGylated Proteins
PEGylated Proteins Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The overall valuation of the pegylated proteins market has seen swift expansion lately; projecting forward, this figure is anticipated to increase from a baseline of $1.47 billion in the year 2024 to reach $1.67 billion by 2025, reflecting a compound annual growth rate (CAGR) of 13.8%. This upward trajectory observed during the historical measurement period stems from several key factors, such as advances leading to better therapeutic effectiveness, the increasing proportion of the global population that is elderly, a rising need for drug formulations that remain active over extended durations, superior characteristics concerning drug safety, and the proliferation of uses across various spheres, notably within systems designed for the focused administration of medicines.
PEGylated Proteins Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated to experience swift expansion, the market volume for pegylated proteins is projected to climb to $2.72 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.9%; this upward trajectory during the projection timeframe stems from several key factors, notably heightened capital allocation towards addressing rare conditions, the vigorous expansion of the biopharmaceutical sector, the refinement of treatments specific to individual patients through precision medicine, escalating rivalry from generic alternatives-biosimilars-to biologic medications, and the implementation of novel methods for gaining market entry for these products.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pegylated-proteins-global-market-report
What Are the Drivers Transforming the PEGylated Proteins Market?
The escalating incidence of ailments linked to lifestyle factors is projected to act as a catalyst for the expansion of the PEGylated proteins market in the future. These lifestyle-related conditions stem largely from detrimental habits and personal choices, encompassing inadequate nutrition, insufficient exercise, and tobacco use, with their rising incidence being attributable to a confluence of elements such as reduced physical exertion, poorer dietary patterns rich in manufactured items, and elevated stress levels. PEGylated proteins demonstrably aid in managing these contemporary illnesses by improving how effectively, how long, and how precisely therapeutic compounds reach targets for ailments like heart conditions, diabetes, and various malignancies. As an illustration, data released in May 2024 by the Office for Health Improvement and Disparities, a governmental organization in the United Kingdom, indicated that roughly 64.0% of individuals aged 18 and older in England were categorized as being overweight or obese during the 2022 to 2023 period, marking a small upward trend from the 63.8% figure recorded in 2021 to 2022. Consequently, this growing rate of lifestyle disease prevalence is directly fueling the forward momentum within the PEGylated proteins market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16145&type=smp
What Long-Term Trends Will Define the Future of the PEGylated Proteins Market?
To bolster their standing within the PEGylated protein arena, leading firms are focusing efforts on creating novel offerings, particularly PEGylation reagents, which are chemical agents designed to affix polyethylene glycol strands to larger biological molecules, thereby modifying their inherent characteristics for diverse uses in medicine and biology. Illustratively, during May of 2023, Creative Enzymes, a provider from the United States known for enzymes and food additives, introduced DSPE-PEG-Maleimide, a specialized tool for directed therapeutic delivery. This compound, identified as DSPE-PEG-MAL, functions as a linear reagent featuring both DSPE phospholipids and a maleimide functional group, making it a beneficial component for creating self-assembling structures like liposomes or micelles coated with PEG, further offering reactive maleimide sites capable of bonding with thiols or cysteines and frequently employed in precise drug targeting strategies.
Which Segments in the PEGylated Proteins Market Offer the Most Profit Potential?
The pegylated proteinsmarket covered in this report is segmented -
1) By Product: Consumable And Services; PEGylation Kits And Reagents; Monofunctional Linear PEGs; Bifunctional PEGs; Services; Other Products
2) By Protein Type: Colony Stimulating Factors; Interferons; Erythropoietin; Recombinant Factor VII; Other Protein Types
3) By Application: Cancer Treatment; Hepatitis; Chronic Kidney Diseases; Hemophilia; Multiple Sclerosis; Gastrointestinal Disorders; Other Applications
4) By End User: Pharmaceuticals; Biotechnology Companies; Contract Research Organizations; Academic Research Institutes
Subsegments:
1) By Consumable And Services: Consumables; Services (Contract Services, PEGylation Services)
2) By PEGylation Kits And Reagents: PEGylation Kits; Reagents
3) By Monofunctional Linear PEGs: Monofunctional PEGs For Protein Modification
4) By Bifunctional PEGs: Bifunctional PEGs For Protein Modification
5) By Other Products: Conjugates; PEGylated Drugs And Therapeutics
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16145&type=smp
Which Firms Dominate the PEGylated Proteins Market by Market Share and Revenue in 2025?
Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.
Which Regions Offer the Highest Growth Potential in the PEGylated Proteins Market?
North America was the largest region in the PEGylated Proteins market in 2024. The regions covered in the PEGylated proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16145
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market : A Key Catalyst Accelerating Global PEGylated Proteins Market Growth in 2025 here
News-ID: 4277355 • Views: …
More Releases from The Business Research Company
Global Oncology Ablation Market Growth Accelerates: Strategic Forecast Predicts …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Oncology Ablation Industry Market Size Be by 2025?
Markedly quick expansion has characterized the oncology ablation market recently, projected to escalate from a valuation of $1.3 billion in 2024 to $1.45 billion the following year, reflecting a compound annual growth rate (CAGR) of 12.1%. Factors driving…
Rising Prevalence Of Neurological Disorders Fuels Demand For Neurogenetic Testin …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Neurogenetic Testing Market Through 2025?
The sphere of neurogenetic testing has seen swift expansion lately, projected to increase its valuation from $0.61 billion in 2024 to $0.7 billion spanning into 2025, reflecting an annual compounded growth rate of 13.5%. This upward trajectory…
Steady Expansion Forecast for Muscle Tension Dysphonia Treatment Market, Project …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Muscle Tension Dysphonia Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The valuation of the muscle tension dysphonia treatment sector has demonstrated consistent upward movement over the past few years, projected to escalate from $12.77 billion presently in 2024 to $13.29 billion by 2025,…
What Is Driving Global Molecular Weight Marker Market Growth in 2025: The Role o …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Molecular Weight Marker Market Size Growth Forecast: What to Expect by 2025?
The market for molecular weight markers has experienced substantial recent expansion, projected to increase from a value of $0.78 billion in 2024 to $0.87 billion just one year later, reflecting an impressive compound annual growth rate of…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
